Using Electrical Impedance Tomography to Investigate the Relationship Between Airflow Rate During High-flow Oxygen Therapy and Pressure in Patients With Heart Failure Compared to Non-invasive Ventilation
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Oct 26, 2023
Trial Information
Current as of September 10, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how two different treatments—High-Flow Oxygen Therapy (HFOT) and Non-Invasive Ventilation (NIV)—affect patients with heart failure. The main goal is to see how the airflow rate during HFOT relates to pressure in the lungs, which could help improve how these therapies are used for breathing support. The study will involve patients in the intensive care unit who are stable and have specific lung issues, such as pulmonary infiltrates on a chest X-ray. Eligible participants must be alert and able to follow instructions.
If you or a loved one joins the trial, you will experience both HFOT and NIV treatments in a specific order over about 1 to 1.5 hours. Your vital signs and breathing patterns will be closely monitored using a special device called Electrical Impedance Tomography (EIT). Participants will be positioned comfortably while the treatments are given, and all data collected will be analyzed later. This study aims to provide more clarity on how these therapies work together, potentially leading to better care for heart failure patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients in the intensive care unit (ICU) with PaO2/FiO2 ≤ 300, requiring Non-Invasive Ventilation (NIV) and High-Flow Oxygen Therapy (HFOT) and stable use of NIV and HFOT for at least 24 hours will be eligible for enrollment.
- • Evidence of pulmonary infiltrates on chest X-ray in patients with heart failure.
- • Alert and able to follow instructions.
- Exclusion Criteria:
- • Age \< 18 years.
- • Patients with a history of tracheostomy.
- • Hemodynamically unstable (defined as a mean arterial pressure persistently below 60 mmHg despite fluid resuscitation or vasopressor support).
- • Severe chronic obstructive pulmonary disease (COPD).
- • History of nasal trauma and/or nasal septal deviation or any other reason preventing the use of High-Flow Oxygen Therapy (HFOT).
- • Presence of facial wounds or any other reason preventing the use of Non-Invasive Ventilation (NIV).
- • Contraindications to Electrical Impedance Tomography (EIT) use (e.g., patients with implanted pacemakers) or inability to place EIT belt (e.g., due to wound dressings or chest drainage).
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, Taiwan
Taipei, Taiwan
Patients applied
Trial Officials
MING-HANN SHIN
Principal Investigator
Division of Respiratory Therapy, Department of Integrated Diagnostic and Therapeutics, National Taiwan University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported